S Bekri

Summary

Affiliation: Rouen University Hospital
Country: France

Publications

  1. pmc Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms
    David Cheillan
    Hospices Civils de Lyon, Service Maladies Héréditaires du Métabolisme et Dépistage Néonatal, Groupement Hospitalier, Bron, France
    Orphanet J Rare Dis 7:96. 2012
  2. ncbi request reprint [Biological diagnosis of lysosomal diseases]
    S Bekri
    Laboratoire de Biochimie Medicale, CHU de Rouen, Hopital Charles Nicolle
    Ann Biol Clin (Paris) 64:592-600. 2006
  3. ncbi request reprint The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature
    Soumeya Bekri
    Department of Biochemistry, Hopital Charles Nicolle, 1 rue de Germont, 76031 Rouen Cedex, France
    Cardiovasc Hematol Agents Med Chem 4:289-97. 2006
  4. ncbi request reprint Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH
    Soumeya Bekri
    Laboratoire d Hépato Gastroentérologie, EA1186, Faculté Médecine de Nice, Nice, France
    Gastroenterology 131:788-96. 2006
  5. ncbi request reprint The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH
    Rodolphe Anty
    INSERM U 568, Nice, France
    Am J Gastroenterol 101:1824-33. 2006
  6. ncbi request reprint Fabry disease in patients with end-stage renal failure: the potential benefits of screening
    Soumeya Bekri
    Department of Biochemistry, Centre Hospitalier Universitaire de Nice, Nice, France
    Nephron Clin Pract 101:c33-8. 2005
  7. doi request reprint Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation
    Rodolphe Anty
    INSERM, U568, Nice, 06107, France
    Obes Surg 18:709-14. 2008
  8. ncbi request reprint [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up]
    Olivier Lidove
    Service de Medecine Interne, Hopital Bichat, Paris
    Presse Med 36:1084-97. 2007
  9. ncbi request reprint [Fabry's disease in 2006: new treatment needs evaluation]
    Olivier Lidove
    Presse Med 35:933-5. 2006
  10. ncbi request reprint [Fabry's disease: role of screening in populations at risk, in the image of chronic hemodialyzed patients]
    Soumeya Bekri
    Service de Biochimie, Centre Hospitalier Universitaire de Nice, France
    Rev Med Suisse Romande 124:677-8. 2004

Collaborators

  • Frederic Barbey
  • Antonio Iannelli
  • Olivier Lidove
  • Rodolphe Anty
  • E Andres
  • David Cheillan
  • Jean Francois Benoist
  • Gilbert Briand
  • Marion Gerard
  • Alexandra Afenjar
  • François Rivier
  • Joseph Vamecq
  • Nicole Porchet
  • Richard Delorme
  • Vassili Valayannopoulos
  • Allel Chabli
  • Jean Marc Pinard
  • Fabienne Prieur
  • Vincent Des Portes
  • Marie Joncquel Chevalier Curt
  • Dries Dobbelaere
  • Gilles Simard
  • Brigitte Chabrol
  • Karine Mention-Mulliez
  • Gajja S Salomons
  • Alice Goldenberg
  • Kumaran Deiva
  • Olivier Douay
  • Marc Tardieu
  • Jean Marie Cuisset
  • Delphine Heron
  • Christine Vianey-Saban
  • Gaelle Pitelet
  • Laurence Lion-Francois
  • François Cartault

Detail Information

Publications11

  1. pmc Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms
    David Cheillan
    Hospices Civils de Lyon, Service Maladies Héréditaires du Métabolisme et Dépistage Néonatal, Groupement Hospitalier, Bron, France
    Orphanet J Rare Dis 7:96. 2012
    ....
  2. ncbi request reprint [Biological diagnosis of lysosomal diseases]
    S Bekri
    Laboratoire de Biochimie Medicale, CHU de Rouen, Hopital Charles Nicolle
    Ann Biol Clin (Paris) 64:592-600. 2006
  3. ncbi request reprint The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature
    Soumeya Bekri
    Department of Biochemistry, Hopital Charles Nicolle, 1 rue de Germont, 76031 Rouen Cedex, France
    Cardiovasc Hematol Agents Med Chem 4:289-97. 2006
    ..The use of CTH measurement in Fabry disease should be re-evaluated in light of recent published data...
  4. ncbi request reprint Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH
    Soumeya Bekri
    Laboratoire d Hépato Gastroentérologie, EA1186, Faculté Médecine de Nice, Nice, France
    Gastroenterology 131:788-96. 2006
    ..We have investigated the possible involvement of hepcidin in massive obesity, a state of chronic low-grade inflammation. Three groups of severely obese patients with or without diabetes or nonalcoholic steatohepatitis were investigated...
  5. ncbi request reprint The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH
    Rodolphe Anty
    INSERM U 568, Nice, France
    Am J Gastroenterol 101:1824-33. 2006
    ..Its clinical usefulness in the diagnosis of NASH was evaluated in severely obese patients without or with MS, diabetes, and NASH and the potential roles of the liver and of the adipose tissue in CRP production were characterized...
  6. ncbi request reprint Fabry disease in patients with end-stage renal failure: the potential benefits of screening
    Soumeya Bekri
    Department of Biochemistry, Centre Hospitalier Universitaire de Nice, Nice, France
    Nephron Clin Pract 101:c33-8. 2005
    ....
  7. doi request reprint Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation
    Rodolphe Anty
    INSERM, U568, Nice, 06107, France
    Obes Surg 18:709-14. 2008
    ..The aim of the present study was to investigate the relationship between iron status and markers of inflammation in morbidly obese women and the effect of bariatric surgery...
  8. ncbi request reprint [Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up]
    Olivier Lidove
    Service de Medecine Interne, Hopital Bichat, Paris
    Presse Med 36:1084-97. 2007
    ..After a proband is identified, a genealogical tree should be used to identify other affected members of the family...
  9. ncbi request reprint [Fabry's disease in 2006: new treatment needs evaluation]
    Olivier Lidove
    Presse Med 35:933-5. 2006
  10. ncbi request reprint [Fabry's disease: role of screening in populations at risk, in the image of chronic hemodialyzed patients]
    Soumeya Bekri
    Service de Biochimie, Centre Hospitalier Universitaire de Nice, France
    Rev Med Suisse Romande 124:677-8. 2004
  11. ncbi request reprint A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia
    Soumeya Bekri
    Department of Human Genetics, Mount Sinai School of Medicine, New York, NY, USA
    Blood 102:698-704. 2003
    ..The dramatic decreases in reporter activity and mRNA level suggest that the region of the mutation may bind a novel and important erythroid regulatory element...